schizoaffective disorder
Information
- Disease name
- schizoaffective disorder
- Disease ID
- DOID:5418
- Description
- "A psychotic disorder that is characterized by recurring episodes of mood fluctuations and a loss of contact with reality." [url:http\://en.wikipedia.org/wiki/Schizoaffective_disorder, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000930.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05660070 | Active, not recruiting | N/A | Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness | July 1, 2022 | December 31, 2024 |
| NCT05658510 | Active, not recruiting | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) | November 21, 2022 | March 30, 2025 |
| NCT03829280 | Active, not recruiting | N/A | Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) | April 4, 2019 | April 2025 |
| NCT03896438 | Active, not recruiting | N/A | Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 | July 1, 2019 | April 2024 |
| NCT01409109 | Active, not recruiting | Database Registry for Neural Network Biomarkers in Psychosis | March 2010 | May 2025 | |
| NCT01941251 | Active, not recruiting | N/A | Navigated αTMS in Treatment-resistant Schizophrenia | March 2013 | December 2025 |
| NCT00512070 | Active, not recruiting | N/A | Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine | July 2007 | December 2025 |
| NCT00057135 | Completed | N/A | Improving Antipsychotic Adherence Among Patients With Serious Mental Illness | November 2002 | September 2006 |
| NCT00057707 | Completed | Phase 1 | Effects of Modafinil on Brain Function in Patients With Schizophrenia | March 26, 2003 | June 16, 2017 |
| NCT00061802 | Completed | Phase 4 | Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder | June 2003 | February 2004 |
| NCT00088465 | Completed | Phase 3 | Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder | August 2004 | December 2010 |
| NCT00090012 | Completed | Phase 4 | Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder | July 2004 | March 2006 |
| NCT00094640 | Completed | Phase 1 | Pharmacokinetic Characterization of Intramuscular Olanzapine Depot | ||
| NCT00095524 | Completed | Phase 3 | Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder | March 2004 | August 2006 |
| NCT00100776 | Completed | Phase 4 | Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder | September 2003 | November 2005 |
| NCT00108199 | Completed | N/A | Generalization of Training in Schizophrenia | October 2001 | September 2004 |
| NCT00119574 | Completed | N/A | Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP) | January 2002 | December 2004 |
| NCT00132314 | Completed | Phase 3 | Long-Acting Injectable Risperidone in the Treatment of Schizophrenia | September 2006 | September 2009 |
| NCT00139906 | Completed | Phase 2 | Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia | August 2005 | October 2006 |
| NCT00139919 | Completed | Phase 2 | Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder | January 2006 | October 2007 |
| NCT00141479 | Completed | Phase 2 | To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox | May 2005 | November 2006 |
| NCT00148083 | Completed | Phase 3 | Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia | September 2005 | March 2006 |
| NCT00156637 | Completed | N/A | A Study of Strategies to Improve Schizophrenia Treatment | June 2005 | March 2008 |
| NCT00156715 | Completed | Phase 4 | Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder | March 2004 | October 2008 |
| NCT00159770 | Completed | Phase 3 | Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients | November 2001 | September 2004 |
| NCT00167310 | Completed | Phase 2 | Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation | September 2005 | December 2015 |
| NCT00169052 | Completed | N/A | Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People | September 2001 | August 2006 |
| NCT00176423 | Completed | Phase 4 | Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia | May 2002 | December 2006 |
| NCT00177008 | Completed | Phase 4 | Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety | March 2004 | January 2007 |
| NCT00177177 | Completed | N/A | L-carnosine for Schizophrenia | March 2004 | December 2007 |
| NCT00177580 | Completed | Phase 4 | Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin | July 2003 | July 2007 |
| NCT00178971 | Completed | Phase 3 | Serotonin 1A Agonists and Cognition in Schizophrenia | January 2003 | October 2004 |
| NCT00179062 | Completed | N/A | Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder | February 2000 | June 2007 |
| NCT00179231 | Completed | N/A | Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia | May 2000 | February 2004 |
| NCT00190749 | Completed | Phase 4 | Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder | October 2003 | June 2008 |
| NCT00202293 | Completed | Phase 4 | Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features | October 1, 2001 | November 1, 2015 |
| NCT00206102 | Completed | Phase 4 | A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder | September 2003 | October 2008 |
| NCT00206544 | Completed | Phase 2 | Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? | January 2004 | December 2007 |
| NCT00206557 | Completed | Phase 2 | The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study | October 2002 | April 2007 |
| NCT00206570 | Completed | Phase 2 | Clinical Estradiol Trial in Women With Schizophrenia | January 2001 | December 2004 |
| NCT00208143 | Completed | Phase 4 | Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia | November 2003 | December 2005 |
| NCT00208169 | Completed | Phase 4 | Abilify Therapy for Reducing Comorbid Substance Abuse | March 2005 | June 2007 |
| NCT00495118 | Completed | Phase 3 | A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. | October 2001 | March 2005 |
| NCT00007774 | Completed | Phase 4 | To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia | March 1998 | |
| NCT00018629 | Completed | Phase 2 | Cognitive - Behavioral Therapy | May 2000 | April 2005 |
| NCT00018642 | Completed | N/A | Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder | April 1997 | March 2002 |
| NCT00034801 | Completed | Phase 4 | Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia | September 2001 | March 2003 |
| NCT00036361 | Completed | Phase 3 | Broad Effectiveness: Study With Aripiprazole | July 2002 | January 2003 |
| NCT00051233 | Completed | Phase 2 | Treatment of Schizophrenia Through Internet-Based Psychoeducation | January 2003 | January 2005 |
| NCT01786239 | Completed | N/A | Omega-3 Dietary Supplements in Schizophrenia | May 2013 | September 2015 |
| NCT01786369 | Completed | Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. | February 2013 | April 2015 | |
| NCT01788774 | Completed | Phase 1 | Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths | April 2013 | February 2014 |
| NCT01793935 | Completed | N/A | Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia | April 2013 | July 7, 2016 |
| NCT01794897 | Completed | Phase 4 | Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia | February 2013 | September 2016 |
| NCT01822418 | Completed | Phase 4 | Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) | January 2013 | December 2015 |
| NCT01828931 | Completed | N/A | Lifestyle Intervention for Diabetes and Weight Management in Psychosis | December 2012 | November 2015 |
| NCT01855074 | Completed | Phase 4 | An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders | November 2007 | February 2009 |
| NCT01866098 | Completed | N/A | Naltrexone for Antipsychotic-Induced Weight Gain | May 2013 | April 7, 2019 |
| NCT01875822 | Completed | Phase 1/Phase 2 | Open-label Study of Curcumin C-3 Complex in Schizophrenia | June 2009 | May 2012 |
| NCT01878513 | Completed | N/A | Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis | September 23, 2009 | July 31, 2018 |
| NCT01880255 | Completed | N/A | rTMS for Working Memory Deficits in Schizophrenia | June 2013 | January 7, 2019 |
| NCT01884025 | Completed | N/A | Get Moving and Get Well - Pilot Study | June 2013 | August 2015 |
| NCT01888107 | Completed | Phase 3 | Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder | January 2005 | April 2007 |
| NCT01915017 | Completed | N/A | Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia | April 2008 | July 2013 |
| NCT01926613 | Completed | N/A | Thinking Skills for Work in Severe Mental Illness | April 2006 | October 2011 |
| NCT01945333 | Completed | N/A | Personalized and Scalable Cognitive Remediation Approaches | September 2013 | March 20, 2019 |
| NCT01952041 | Completed | N/A | A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia | March 13, 2015 | August 7, 2017 |
| NCT01963676 | Completed | N/A | Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia | January 2014 | October 2014 |
| NCT01969500 | Completed | N/A | Development of a Mobile System for Self-management of Schizophrenia (SOS) | November 2015 | February 2017 |
| NCT01975584 | Completed | N/A | Neuroendocrine and Immune Response to Stress in Schizophrenia | September 2013 | June 2018 |
| NCT01981759 | Completed | Phase 4 | D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions | February 2014 | October 2017 |
| NCT01992393 | Completed | N/A | Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME) | September 2013 | September 2015 |
| NCT01992913 | Completed | N/A | Building Employment Skills Through Therapy for Veterans | June 12, 2015 | August 31, 2020 |
| NCT01999309 | Completed | Phase 3 | Simvastatin Addition for Patients With Recent-onset Schizophrenia | October 2013 | December 19, 2019 |
| NCT02032680 | Completed | N/A | Comparison of E-health vs. In-person Multi-Family Group (MFG) | August 19, 2015 | September 30, 2018 |
| NCT02034253 | Completed | Glutamate, Brain Connectivity and Duration of Untreated Psychosis | January 2014 | November 2018 | |
| NCT02034474 | Completed | Phase 4 | Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia | February 2014 | February 6, 2017 |
| NCT02055287 | Completed | Phase 1 | Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder | March 2013 | June 2014 |
| NCT02069392 | Completed | N/A | Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia | January 2015 | June 2017 |
| NCT02074319 | Completed | Phase 1 | RCT of Methotrexate Added to Treatment As Usual in Schizophrenia | December 2013 | August 2015 |
| NCT02075528 | Completed | Phase 4 | Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER | July 2009 | July 2012 |
| NCT02085447 | Completed | N/A | A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness | May 2014 | December 2016 |
| NCT02090335 | Completed | N/A | Health Promotion and Fitness for Younger and Older Adults With SMI | May 2007 | May 2013 |
| NCT02091388 | Completed | Phase 1 | Bioavailability of LY03004 and Risperdal® Consta® | September 2014 | January 2015 |
| NCT02124811 | Completed | Phase 4 | Minocycline Augmentation to Clozapine | February 2015 | November 2016 |
| NCT02131116 | Completed | N/A | Integrated Metacognitive Therapy in First Episode Psychosis | May 2014 | December 2017 |
| NCT02131129 | Completed | N/A | rTMS in First Episode Psychosis | April 30, 2014 | December 2016 |
| NCT02137993 | Completed | Phase 4 | Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia | March 2012 | May 2013 |
| NCT02160249 | Completed | N/A | RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) | September 2015 | May 8, 2017 |
| NCT02186769 | Completed | Phase 1 | An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder | July 2014 | April 2015 |
| NCT02188121 | Completed | Phase 4 | Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients | February 2015 | October 2021 |
| NCT02188732 | Completed | N/A | Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes | January 2015 | July 31, 2021 |
| NCT02199743 | Completed | Phase 4 | Lurasidone Effects on Tissue Glutamate in Schizophrenia | February 2013 | June 2016 |
| NCT02224430 | Completed | Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors | August 2014 | December 31, 2019 | |
| NCT02237235 | Completed | Phase 2 | Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia | August 2014 | August 2017 |
| NCT02267070 | Completed | N/A | Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode | November 2013 | July 2017 |
| NCT02308956 | Completed | Phase 3 | Task Sharing for the Care of Severe Mental Disorders in a Low-income Country | March 2015 | November 16, 2017 |
| NCT02326389 | Completed | N/A | Exercise and Cognitive Training | May 2015 | November 2017 |
| NCT02334228 | Completed | N/A | Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness | September 2006 | August 2009 |
| NCT02334280 | Completed | N/A | Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI | September 2009 | May 2013 |
| NCT02354001 | Completed | Phase 4 | Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia | April 2011 | January 2019 |
| NCT02360228 | Completed | N/A | STimulation to Improve Auditory haLLucinations | May 2015 | February 2017 |
| NCT02360813 | Completed | N/A | Cognitive Remediation Therapy Within a Secure Forensic Setting | August 2014 | January 2017 |
| NCT02364544 | Completed | N/A | Improving Care and Reducing Cost Study | April 2013 | June 2015 |
| NCT02386605 | Completed | N/A | Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers | March 28, 2016 | June 30, 2020 |
| NCT02398279 | Completed | N/A | L-arginine add-on Therapy in Patients With Schizophrenia | June 2011 | April 2013 |
| NCT02411526 | Completed | Phase 1 | Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia | February 2015 | September 2015 |
| NCT02415764 | Completed | Phase 1 | OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant | June 2015 | March 2016 |
| NCT02417142 | Completed | Phase 4 | Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia | September 2014 | July 2020 |
| NCT02421965 | Completed | N/A | Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental Illness | June 2015 | December 2017 |
| NCT02453217 | Completed | N/A | The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial | March 31, 2016 | January 31, 2019 |
| NCT02504151 | Completed | Phase 2 | Cannabidiol Treatment in Patients With Early Psychosis | January 28, 2016 | March 9, 2018 |
| NCT02566057 | Completed | N/A | Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis | July 10, 2014 | December 31, 2017 |
| NCT02573168 | Completed | N/A | Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics | January 2016 | September 2020 |
| NCT02576613 | Completed | N/A | Modified Psychodynamic Psychotherapy for Patients With Schizophrenia | October 2015 | December 2022 |
| NCT02582736 | Completed | Antipsychotics and Risk of Hyperglycemic Emergencies | April 2012 | December 2012 | |
| NCT02593058 | Completed | N/A | Positive Emotions Program for Schizophrenia (PEPS) | February 1, 2016 | December 31, 2018 |
| NCT02636842 | Completed | Phase 1 | A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder | December 2015 | June 2016 |
| NCT02640300 | Completed | Phase 4 | Switching Antipsychotics: Abrupt Discontinuation Versus Overlap | May 1999 | July 2004 |
| NCT02642029 | Completed | N/A | Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study | February 18, 2016 | June 14, 2019 |
| NCT02664129 | Completed | N/A | Video as a Tool to Improve Insight in Schizophrenia | December 8, 2015 | December 30, 2018 |
| NCT02775864 | Completed | Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia | July 2015 | June 2018 | |
| NCT02782442 | Completed | N/A | Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) | September 1, 2016 | March 12, 2022 |
| NCT02787122 | Completed | N/A | Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia | January 1, 2014 | December 31, 2017 |
| NCT02810964 | Completed | Phase 2 | Sulforaphane to Reduce Symptoms of Schizophrenia | February 22, 2017 | November 11, 2019 |
| NCT02815813 | Completed | N/A | Lifestyle Intervention for Young Adults With Serious Mental Illness | July 3, 2017 | May 31, 2022 |
| NCT02819349 | Completed | N/A | Texting for Relapse Prevention | March 12, 2018 | April 9, 2019 |
| NCT02823041 | Completed | N/A | Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode | October 13, 2016 | June 30, 2023 |
| NCT02869334 | Completed | N/A | Remediation of Auditory Recognition in Schizophrenia With tDCS | June 2016 | January 31, 2020 |
| NCT02901587 | Completed | Phase 1 | Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder | September 2016 | April 18, 2018 |
| NCT02921243 | Completed | Schizophrenia and the Gut Microbiome | October 1, 2016 | June 18, 2019 | |
| NCT02930005 | Completed | Phase 2 | Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders | August 7, 2015 | October 6, 2016 |
| NCT02978599 | Completed | Phase 1 | Clinical Trial of AVL-3288 in Schizophrenia Patients | November 2016 | November 2, 2018 |
| NCT03037983 | Completed | N/A | Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation | August 1, 2017 | July 18, 2019 |
| NCT03043820 | Completed | Phase 3 | Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder | August 2016 | July 1, 2021 |
| NCT03049813 | Completed | N/A | Virtual Reality Job Interview Training in Severe Mental Illness | June 1, 2017 | July 31, 2022 |
| NCT03050853 | Completed | N/A | The Appeal and Impact of E-cigarettes in Smokers With SMI | March 1, 2017 | January 31, 2021 |
| NCT03062267 | Completed | N/A | Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness | October 1, 2017 | May 31, 2020 |
| NCT03076346 | Completed | Neural Biomarkers of Clozapine Response | September 1, 2017 | December 31, 2020 | |
| NCT03079024 | Completed | N/A | Minnesota Community-Based Cognitive Training in Early Psychosis | May 19, 2017 | March 26, 2022 |
| NCT03179696 | Completed | N/A | Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia | August 15, 2016 | October 31, 2018 |
| NCT03197168 | Completed | N/A | Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile | March 2014 | March 2016 |
| NCT03288779 | Completed | N/A | Theta Burst Stimulation for Schizophrenia | October 24, 2017 | June 30, 2018 |
| NCT03316664 | Completed | N/A | Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis | June 1, 2018 | August 31, 2021 |
| NCT03370341 | Completed | N/A | Stimulating the Brain to Improve Self-Awareness | December 1, 2017 | December 1, 2019 |
| NCT03388554 | Completed | N/A | The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia | July 2016 | March 2, 2018 |
| NCT03390491 | Completed | N/A | OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis | November 1, 2018 | July 31, 2021 |
| NCT03404219 | Completed | N/A | Motivation and Skills Support (MASS) | November 1, 2018 | May 11, 2020 |
| NCT03409393 | Completed | N/A | Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis | January 22, 2018 | August 1, 2018 |
| NCT03510741 | Completed | Phase 2 | Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. | January 1, 2019 | March 30, 2021 |
| NCT03526354 | Completed | Phase 4 | Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder | March 19, 2018 | February 29, 2024 |
| NCT03559426 | Completed | Phase 4 | Research Into Antipsychotic Discontinuation and Reduction Trial | March 24, 2016 | March 10, 2022 |
| NCT03568500 | Completed | Phase 4 | A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic | May 21, 2018 | September 6, 2019 |
| NCT03571685 | Completed | N/A | Sustainable Early Episode Clinic Study (SEEC) | January 31, 2017 | December 20, 2019 |
| NCT03576976 | Completed | N/A | Improving Accessibility and Personalization of CR for Schizophrenia | July 16, 2018 | May 30, 2022 |
| NCT03617783 | Completed | Phase 4 | Prebiotic Treatment in People With Schizophrenia - Pilot Study | July 18, 2019 | April 5, 2022 |
| NCT03621774 | Completed | N/A | Mobile CBT for Negative Symptoms | March 27, 2019 | August 31, 2022 |
| NCT03701100 | Completed | N/A | The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia | July 17, 2017 | September 21, 2018 |
| NCT03751488 | Completed | Phase 1 | A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients | December 12, 2018 | July 24, 2019 |
| NCT03757988 | Completed | N/A | Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life | December 6, 2018 | September 11, 2019 |
| NCT03848234 | Completed | Phase 3 | Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder | December 4, 2015 | July 29, 2016 |
| NCT03860597 | Completed | Phase 4 | Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia | April 1, 2018 | March 31, 2021 |
| NCT03873337 | Completed | N/A | Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) | April 22, 2019 | January 31, 2022 |
| NCT03880227 | Completed | N/A | Improving Visual Attention in Schizophrenia | March 25, 2019 | March 4, 2020 |
| NCT03921450 | Completed | N/A | Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) | March 25, 2019 | February 10, 2023 |
| NCT03930251 | Completed | N/A | Cognitive Remediation for Coordinated Specialty Care | June 1, 2019 | December 31, 2023 |
| NCT04011280 | Completed | Phase 4 | Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness | August 12, 2019 | March 4, 2022 |
| NCT04038788 | Completed | N/A | Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia | October 24, 2018 | May 17, 2019 |
| NCT04068467 | Completed | N/A | Evaluation of mHealth for Serious Mental Illness | January 6, 2020 | May 1, 2021 |
| NCT04173572 | Completed | N/A | Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial | December 20, 2019 | March 23, 2022 |
| NCT04251195 | Completed | N/A | Verbal Memory Training Using Virtual Reality in Schizophrenia | February 12, 2019 | February 17, 2023 |
| NCT04268303 | Completed | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia | January 24, 2020 | May 6, 2020 |
| NCT04284813 | Completed | N/A | Families With Substance Use and Psychosis: A Pilot Study | September 24, 2020 | July 7, 2022 |
| NCT04418011 | Completed | N/A | Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders | November 30, 2020 | February 2, 2023 |
| NCT04545294 | Completed | N/A | Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia | August 14, 2019 | April 10, 2020 |
| NCT04673851 | Completed | N/A | Horyzons: Implementation in Clinical Practice | January 19, 2021 | August 31, 2023 |
| NCT04783285 | Completed | N/A | Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders | March 29, 2021 | December 31, 2021 |
| NCT04870710 | Completed | N/A | Feasibility Electrical Stimulation Study for Visual Hallucinations | October 1, 2020 | January 2, 2022 |
| NCT04874974 | Completed | N/A | Feasibility of a Novel Process-based Treatment for Patients With Psychosis | May 10, 2021 | September 23, 2023 |
| NCT05105542 | Completed | Phase 2 | M1 Schizophrenia PET Study | April 20, 2021 | October 31, 2023 |
| NCT05712928 | Completed | N/A | eMove - Dance/Movement Therapy Study | June 29, 2021 | December 31, 2022 |
| NCT05746455 | Completed | N/A | Motivation Skills Training for Schizophrenia | May 30, 2023 | December 31, 2023 |
| NCT05779241 | Completed | Phase 3 | Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 | April 13, 2023 | December 1, 2023 |
| NCT05784948 | Completed | N/A | Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis | April 8, 2020 | June 9, 2021 |
| NCT00212771 | Completed | Phase 3 | Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) | September 2004 | October 2006 |
| NCT00212784 | Completed | Phase 3 | Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) | September 4, 2003 | March 15, 2006 |
| NCT00215579 | Completed | Phase 4 | Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence | April 2004 | April 2006 |
| NCT00222235 | Completed | Phase 2/Phase 3 | Adjunctive Treatment for Decreasing Symptoms of Schizophrenia | January 2000 | June 2004 |
| NCT00222794 | Completed | Phase 4 | A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia | November 2003 | July 2006 |
| NCT00222807 | Completed | Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus | August 2003 | March 2016 | |
| NCT00223418 | Completed | N/A | Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills | January 2004 | June 2007 |
| NCT00224822 | Completed | Phase 4 | The Effects of Aripiprazole on Patients With Metabolic Syndrome | March 2004 | March 2007 |
| NCT00231335 | Completed | Phase 4 | Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia | March 2006 | July 2007 |
| NCT00237796 | Completed | N/A | Functional Rehabilitation of Older Patients With Schizophrenia | February 2005 | January 2009 |
| NCT00237809 | Completed | Phase 3 | D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia | September 2002 | September 2012 |
| NCT00237848 | Completed | Phase 3 | D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia | February 2005 | |
| NCT00246259 | Completed | Phase 4 | A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis | October 2004 | December 2008 |
| NCT00253110 | Completed | Phase 4 | A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder | May 1996 | September 1998 |
| NCT00261716 | Completed | Phase 3 | Motivational Interviewing to Improve Work Outcomes in Schizophrenia | January 2005 | February 2010 |
| NCT00269919 | Completed | Phase 4 | An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia | August 2005 | August 2008 |
| NCT00283179 | Completed | Phase 3 | Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia | March 2004 | December 2004 |
| NCT00287352 | Completed | Phase 1 | Study of Amantadine for Weight Stabilization During Olanzapine Treatment | May 2005 | September 2009 |
| NCT00288340 | Completed | N/A | Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging | January 2006 | August 2006 |
| NCT00288366 | Completed | N/A | Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome | January 2006 | December 2008 |
| NCT00297388 | Completed | Phase 3 | A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder | September 2004 | |
| NCT00297947 | Completed | Phase 2/Phase 3 | High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder | December 2004 | October 2014 |
| NCT00303602 | Completed | Phase 4 | Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) | March 2006 | December 2007 |
| NCT00304655 | Completed | Phase 4 | Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) | July 2004 | October 2007 |
| NCT00306475 | Completed | Phase 4 | Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? | March 2006 | April 2008 |
| NCT00312598 | Completed | Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine | August 2005 | April 2010 | |
| NCT00313391 | Completed | Phase 4 | Risperdal Consta and Health Care Utilization in Patients With Schizophrenia | December 2005 | |
| NCT00316303 | Completed | Phase 2 | Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder | February 2006 | August 2012 |
| NCT00320697 | Completed | Phase 4 | Smoking Relapse Prevention in Schizophrenia | April 2006 | August 2009 |
| NCT00320723 | Completed | Phase 4 | Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia | July 2001 | December 2005 |
| NCT00320736 | Completed | Phase 4 | Galantamine for Cognition in People With Schizophrenia | January 2004 | May 2006 |
| NCT00325689 | Completed | Phase 4 | Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. | July 2006 | October 2007 |
| NCT00330863 | Completed | Phase 4 | Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy | May 2006 | January 2011 |
| NCT00337662 | Completed | Phase 4 | Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia | May 2006 | December 2007 |
| NCT00349973 | Completed | N/A | Clinical Trial of Dipyridamole in Schizophrenia | May 2001 | September 2011 |
| NCT00350883 | Completed | Phase 2 | Cognitive Therapy for Negative Symptoms and Functioning | July 2006 | November 2011 |
| NCT00357006 | Completed | Phase 2 | A Definitive Estrogen Patch Study (ADEPT) | July 2006 | December 2013 |
| NCT00361543 | Completed | Phase 4 | Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia | August 2006 | December 2014 |
| NCT00362804 | Completed | N/A | Tetrabenazine for Partial Responders | February 2002 | January 2006 |
| NCT00369239 | Completed | Phase 4 | Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis | March 2006 | November 2007 |
| NCT00373126 | Completed | Phase 4 | The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia | April 2005 | |
| NCT00373672 | Completed | Phase 4 | Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder | August 2006 | January 2010 |
| NCT00378183 | Completed | Phase 4 | A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. | February 2001 | May 2002 |
| NCT00391261 | Completed | Phase 4 | An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. | July 2006 | October 2007 |
| NCT00395031 | Completed | Phase 2/Phase 3 | Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder | September 2003 | January 2010 |
| NCT00397033 | Completed | Phase 3 | Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. | November 2006 | February 2008 |
| NCT00399334 | Completed | PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders | June 2005 | December 2005 | |
| NCT00400166 | Completed | N/A | Recovery Guide Intervention for Recurrent Psychiatric Hospitalization | December 2006 | May 2009 |
| NCT00401089 | Completed | Phase 1/Phase 2 | Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia | December 2002 | October 2007 |
| NCT00403247 | Completed | N/A | Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia | July 2004 | July 2007 |
| NCT00406315 | Completed | Phase 4 | Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone | November 2006 | March 2009 |
| NCT00406718 | Completed | N/A | Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia | November 2006 | July 2013 |
| NCT00407277 | Completed | N/A | Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia | February 2007 | |
| NCT00412373 | Completed | Phase 3 | Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. | December 2006 | June 2008 |
| NCT00419146 | Completed | Phase 2/Phase 3 | Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants | September 2001 | April 2004 |
| NCT00421954 | Completed | Phase 3 | Open-label Ziprasidone Study for Psychosis Treatment in Adolescents | May 2006 | May 2009 |
| NCT00423878 | Completed | Phase 4 | Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder | January 2007 | March 2010 |
| NCT00423943 | Completed | Phase 4 | Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia | September 2005 | December 2012 |
| NCT00430560 | Completed | Phase 2/Phase 3 | Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia | October 2000 | October 2015 |
| NCT00431184 | Completed | Phase 2 | Effects of Pentazocine Versus Lorazepam on Manic Symptoms | January 2007 | March 2011 |
| NCT00434980 | Completed | N/A | Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia | February 2005 | February 2015 |
| NCT00453609 | Completed | Phase 4 | Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) | April 2007 | October 2008 |
| NCT00458211 | Completed | Phase 4 | Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics | May 2005 | April 2008 |
| NCT00458367 | Completed | RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice | June 2002 | October 2006 | |
| NCT00466323 | Completed | N/A | The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. | September 2007 | June 2011 |
| NCT00470106 | Completed | N/A | Improving Basic and Social Cognition in Veterans With Schizophrenia | September 2007 | September 2009 |
| NCT00480571 | Completed | Phase 2 | Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder | June 2007 | December 2007 |
| NCT00492349 | Completed | Phase 4 | Varenicline Adjunctive Treatment in Schizophrenia | May 2007 | April 2011 |
| NCT00498550 | Completed | Phase 4 | Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual | October 2000 | March 2009 |
| NCT00499044 | Completed | N/A | A Comparison of Two Cognitive Batteries in People With Schizophrenia | December 2007 | March 2009 |
| NCT00500695 | Completed | Phase 1 | Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness | May 2006 | October 2013 |
| NCT00501618 | Completed | Phase 4 | Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder | November 2006 | July 2009 |
| NCT00507988 | Completed | N/A | Complex Problem Solving Training in Schizophrenic Patients | August 2007 | February 2009 |
| NCT00514423 | Completed | N/A | How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs | September 2006 | December 2011 |
| NCT00514449 | Completed | Phase 2 | Systematic Evaluation of Antiviral Medication in Schizophrenia | June 2007 | September 2016 |
| NCT00515723 | Completed | N/A | Glucose and Lipid Metabolism on Antipsychotic Medication | September 2001 | December 2008 |
| NCT00520650 | Completed | Phase 4 | Health Evaluation of Abilify Long-term Therapy | August 2006 | April 2009 |
| NCT00522613 | Completed | N/A | Recovery Group Pilot | July 2005 | December 2006 |
| NCT00523783 | Completed | Seroquel Long-Term NIS for Schizophrenia Patients | May 2007 | May 2008 | |
| NCT00535145 | Completed | Phase 4 | Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease | October 2007 | February 2009 |
| NCT00538122 | Completed | Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment | July 2007 | September 2008 | |
| NCT00538642 | Completed | N/A | Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone | August 2007 | November 2011 |
| NCT00539071 | Completed | Phase 4 | High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone | March 2008 | May 2012 |
| NCT00545467 | Completed | Phase 4 | Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents | August 2007 | July 2009 |
| NCT00558298 | Completed | Phase 3 | A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. | February 2000 | February 2005 |
| NCT00566735 | Completed | Phase 3 | The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning | July 2004 | January 2008 |
| NCT00588731 | Completed | Phase 2 | Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia | February 2009 | December 2013 |
| NCT00595504 | Completed | Phase 4 | Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia | January 2008 | March 2010 |
| NCT00615511 | Completed | Phase 2 | Efficacy of Pregnenolone in Patients With Schizophrenia | June 2007 | December 2014 |
| NCT00621777 | Completed | Phase 4 | A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder | February 2008 | May 2013 |
| NCT00641745 | Completed | Phase 3 | Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia | March 2008 | July 2010 |
| NCT00644852 | Completed | Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone | January 2007 | September 2007 | |
| NCT00645944 | Completed | N/A | Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia | April 2008 | April 2011 |
| NCT00646581 | Completed | Phase 4 | Effect of Single Dose Intranasal Insulin On Cognitive Function | October 2006 | January 2010 |
| NCT00649064 | Completed | Phase 4 | A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs | December 2003 | September 2004 |
| NCT00650429 | Completed | Phase 4 | A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder | October 2003 | May 2005 |
| NCT00650611 | Completed | Phase 2 | A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders | December 2003 | March 2005 |
| NCT00661869 | Completed | N/A | Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness | September 2006 | January 2008 |
| NCT00683709 | Completed | Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder | January 2007 | July 2011 | |
| NCT00688259 | Completed | N/A | Cognitive-Behavioral Therapy in Veterans With Schizophrenia | April 2009 | January 2015 |
| NCT00688324 | Completed | Phase 4 | Biomarker Study of Acamprosate in Schizophrenia | June 2008 | February 2012 |
| NCT00690235 | Completed | Phase 4 | Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia | November 2007 | August 2011 |
| NCT00709202 | Completed | Phase 2 | Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain | July 2008 | December 2016 |
| NCT00713804 | Completed | Phase 3 | Impact of Genetic Counseling for Individuals With Mental Illness | July 2008 | November 2011 |
| NCT00714818 | Completed | Phase 3 | Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness | August 2008 | November 2011 |
| NCT00716755 | Completed | N/A | Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. | October 2009 | August 2015 |
| NCT00727103 | Completed | Phase 4 | Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia | July 2008 | May 2011 |
| NCT00728728 | Completed | Phase 2 | Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia | December 2009 | December 2015 |
| NCT00749970 | Completed | Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia | July 2008 | January 2009 | |
| NCT00753506 | Completed | N/A | Artemisinin to Reduce The Symptoms of Schizophrenia | August 2008 | May 2010 |
| NCT00791349 | Completed | Phase 1 | A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone | February 2005 | May 2005 |
| NCT00791440 | Completed | N/A | Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy | November 2008 | June 2012 |
| NCT00791622 | Completed | Phase 1 | A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine | January 2006 | June 2006 |
| NCT00793780 | Completed | N/A | Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia | December 2008 | November 2010 |
| NCT00796081 | Completed | Phase 1 | A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | January 2006 | August 2006 |
| NCT00796185 | Completed | Phase 1 | As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations | August 2003 | January 2004 |
| NCT00797277 | Completed | Phase 3 | Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia | July 2006 | June 2009 |
| NCT00817154 | Completed | Phase 1 | Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) | November 2009 | December 2013 |
| NCT00817336 | Completed | Phase 2 | Biomarkers in Schizophrenia | June 2009 | July 2011 |
| NCT00818298 | Completed | N/A | 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study | January 2009 | June 2011 |
| NCT00833976 | Completed | Phase 4 | Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia | July 2009 | March 2013 |
| NCT00836251 | Completed | Effects of Antipsychotic Medications on Energy Intake and Expenditure | April 2006 | June 2008 | |
| NCT00864825 | Completed | Phase 4 | Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia | August 2009 | January 2010 |
| NCT00914238 | Completed | N/A | Extended Specialized Assertive Intervention for First Episode Psychosis | July 2009 | October 2016 |
| NCT00918021 | Completed | Phase 4 | Polypharmacy in Clozapine-resistant Schizophrenia | June 2009 | July 2010 |
| NCT00929955 | Completed | Phase 1 | Role of Anti-Inflammatory Agents in Patients With Schizophrenia | June 2009 | September 2010 |
| NCT00936351 | Completed | N/A | Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia | December 2007 | December 2010 |
| NCT00946348 | Completed | Phase 1 | Cannabis and Schizophrenia: Self-Medication and Agonist Treatment | December 2009 | October 2012 |
| NCT00960375 | Completed | Phase 2/Phase 3 | Smoking Cessation for Veterans With Severe and Persistent Mental Illness | April 2010 | December 2014 |
| NCT00981526 | Completed | Phase 4 | Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia | March 2009 | May 2012 |
| NCT00990925 | Completed | N/A | Lifestyle Modification for Weight Loss in Schizophrenia | October 2009 | February 2012 |
| NCT00995553 | Completed | N/A | Remediation of Working Memory in Schizophrenia | January 2010 | December 2015 |
| NCT01001481 | Completed | Schizophrenia Treatment Adherence Investigation (STAI) | July 2007 | September 2009 | |
| NCT01004354 | Completed | N/A | Vitamin D Supplementation in Psychiatric Illnesses | June 2009 | June 2010 |
| NCT01028196 | Completed | Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression | November 2009 | November 2010 | |
| NCT01028677 | Completed | N/A | Oxytocin Treatment of Schizophrenia | November 2009 | March 2011 |
| NCT01029769 | Completed | N/A | Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia | December 2009 | March 2015 |
| NCT01036282 | Completed | Phase 4 | Cognitive Skills Training Using Computer for Patients With Severe Mental Illness | February 2003 | December 2016 |
| NCT01043250 | Completed | Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients | May 2009 | December 2010 | |
| NCT01065597 | Completed | Phase 1 | Nonconvulsive Electrotherapy: a Proof-of-concept Trial | May 2010 | April 2014 |
| NCT01075295 | Completed | N/A | Prevention of Weight Gain in Early Psychoses | February 2010 | December 2012 |
| NCT01092598 | Completed | Factors Association With Poor Physical Function in Older Adults With Schizophrenia | March 2010 | May 2015 | |
| NCT01093365 | Completed | Phase 2 | Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia | March 2010 | August 2016 |
| NCT01101464 | Completed | Phase 2 | A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) | October 2002 | December 2002 |
| NCT01136772 | Completed | Phase 4 | A Comparison of Long-acting Injectable Medications for Schizophrenia | March 2011 | July 2016 |
| NCT01143077 | Completed | Phase 3 | A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents | June 2010 | May 2011 |
| NCT01143090 | Completed | Phase 3 | A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder | August 2010 | |
| NCT01169142 | Completed | Phase 4 | Study of Vitamin D in the Severely Mentally Ill | January 2010 | December 2015 |
| NCT01175642 | Completed | Early Phase 1 | Cognitive Remediation and Functional Skills Training in Schizophrenia | July 2007 | September 2010 |
| NCT01193153 | Completed | Phase 3 | A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder | September 2010 | October 2013 |
| NCT01196286 | Completed | N/A | Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis | June 2010 | April 2017 |
| NCT01198353 | Completed | Phase 4 | Effectiveness of Ziprasidone for Patients With Schizophrenia | September 2010 | December 2013 |
| NCT01216891 | Completed | N/A | Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis | October 2010 | August 2016 |
| NCT01242371 | Completed | N/A | Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia | August 2010 | August 2012 |
| NCT01248195 | Completed | Phase 4 | Optimization of Treatment and Management of Schizophrenia in Europe | May 2011 | April 2016 |
| NCT01259427 | Completed | Phase 2 | Reducing Internalized Stigma in People With Serious Mental Illness | October 2011 | September 2015 |
| NCT01269710 | Completed | Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study | October 2009 | March 2011 | |
| NCT01292577 | Completed | Phase 1/Phase 2 | Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia | September 2010 | September 2014 |
| NCT01309373 | Completed | An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia | November 2010 | August 2011 | |
| NCT01321177 | Completed | N/A | An Integrated Program for the Treatment of First Episode of Psychosis | July 2010 | July 2017 |
| NCT01339858 | Completed | Phase 4 | The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia | May 2011 | December 2015 |
| NCT01384604 | Completed | Neurophysiological Studies in Schizophrenia and Psychiatric Disorders | December 2007 | May 2013 | |
| NCT01385709 | Completed | The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels | August 2008 | August 2013 | |
| NCT01394471 | Completed | Phase 1 | Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia | July 2011 | January 2015 |
| NCT01400477 | Completed | Phase 2 | Nicotinic Receptors and Schizophrenia | July 2011 | June 2015 |
| NCT01423916 | Completed | Phase 1 | Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder | July 2011 | March 2012 |
| NCT01425671 | Completed | Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States | November 30, 2010 | January 2024 | |
| NCT01425684 | Completed | Brain Circuits in Schizophrenia and Smoking | December 20, 2010 | April 2021 | |
| NCT01431092 | Completed | Phase 4 | Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia | October 2011 | June 2014 |
| NCT01450514 | Completed | Phase 2 | POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia | March 2012 | December 2012 |
| NCT01481883 | Completed | Phase 4 | Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? | January 2012 | February 2019 |
| NCT01487668 | Completed | N/A | Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders | December 2011 | May 2015 |
| NCT01490086 | Completed | Phase 2 | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder | December 2011 | March 2013 |
| NCT01519557 | Completed | Early Phase 1 | Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders | April 2011 | November 2013 |
| NCT01521026 | Completed | N/A | Cognitive Training for Patients With Schizophrenia | September 2003 | August 2009 |
| NCT01542229 | Completed | N/A | PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) | May 3, 2012 | December 31, 2016 |
| NCT01555814 | Completed | N/A | Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen | May 2011 | October 2016 |
| NCT01556763 | Completed | Phase 1 | Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia | April 2008 | August 2008 |
| NCT01561859 | Completed | N/A | Brain Imaging, Cognitive Enhancement and Early Schizophrenia | June 2012 | June 2018 |
| NCT01570972 | Completed | N/A | Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis | February 2010 | April 2017 |
| NCT01578486 | Completed | Phase 4 | Salsalate as an Adjunctive Treatment for Patients With Schizophrenia | June 2011 | July 2015 |
| NCT01596608 | Completed | N/A | Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder | February 2012 | June 2019 |
| NCT01602029 | Completed | Phase 2 | Randomized Double Blind Placebo Control Study in Patients With Schizophrenia | August 2010 | June 2013 |
| NCT01609153 | Completed | Phase 4 | Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy | June 2012 | April 2019 |
| NCT01658150 | Completed | N/A | Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder | September 2012 | January 2, 2018 |
| NCT01683539 | Completed | N/A | Understanding How Cognitive Remediation Works | September 2012 | March 11, 2019 |
| NCT01706965 | Completed | Phase 1/Phase 2 | Kuvan in People With Schizophrenia and Schizoaffective Disorder | October 2012 | June 2016 |
| NCT01731119 | Completed | Phase 2 | Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents | December 2012 | August 2014 |
| NCT01731171 | Completed | N/A | Probiotics to Prevent Relapse After Hospitalization for Mania | November 2012 | December 2016 |
| NCT01752712 | Completed | N/A | Oxytocin and CBSST for People With Schizophrenia | January 2014 | August 2016 |
| NCT01780116 | Completed | Phase 1/Phase 2 | Effectiveness of Adherence Therapy for Schizophrenia | May 2013 | February 2016 |
| NCT04554121 | Enrolling by invitation | N/A | Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing | December 14, 2020 | May 1, 2025 |
| NCT05567848 | Enrolling by invitation | Phase 1/Phase 2 | Accelerated TMS in Psychosis | November 29, 2022 | January 2025 |
| NCT06251193 | Not yet recruiting | N/A | Optimizing CBSST With Executive Function Training for Schizophrenia | March 15, 2024 | February 1, 2027 |
| NCT06107764 | Not yet recruiting | N/A | Cerebellar Modulation of Cognition in Psychosis | April 2024 | December 2029 |
| NCT05416658 | Not yet recruiting | N/A | Shared Decision Making for Antipsychotic Medications | January 1, 2025 | June 30, 2025 |
| NCT03974620 | Not yet recruiting | N/A | Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia | December 1, 2024 | December 30, 2024 |
| NCT05974527 | Not yet recruiting | Phase 4 | Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department | September 1, 2023 | June 30, 2026 |
| NCT05457127 | Not yet recruiting | N/A | Obstructive Sleep Apnea Treatment in Serious Mental Illness | January 1, 2024 | November 2026 |
| NCT06286202 | Not yet recruiting | N/A | Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial | May 2024 | July 2027 |
| NCT04324944 | Recruiting | N/A | Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness | July 5, 2022 | March 31, 2025 |
| NCT05824117 | Recruiting | N/A | Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education. | October 18, 2022 | March 31, 2025 |
| NCT04013555 | Recruiting | Phase 1/Phase 2 | The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia | January 20, 2020 | June 30, 2024 |
| NCT01888627 | Recruiting | N/A | Integrated Care in Psychotic Disorders With Severe Mental Illness | May 2007 | December 2025 |
| NCT02639702 | Recruiting | Phase 4 | Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia | August 2016 | December 2026 |
| NCT05877716 | Recruiting | N/A | EPI-MINN: Targeting Cognition and Motivation - National | May 30, 2023 | July 2025 |
| NCT05805397 | Recruiting | N/A | Effectiveness of Motivation Skills Training (MST) | April 15, 2024 | November 2025 |
| NCT04414930 | Recruiting | Phase 2 | Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia | November 9, 2020 | December 2024 |
| NCT04226898 | Recruiting | Phase 2 | Synbiotic Compound to Reduce Symptoms of Schizophrenia | February 21, 2022 | January 2025 |
| NCT06003036 | Recruiting | N/A | Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine | December 1, 2023 | September 2025 |
| NCT05859698 | Recruiting | Phase 4 | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia | May 25, 2023 | December 2024 |
| NCT00178932 | Recruiting | N/A | Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors | November 1998 | December 2023 |
| NCT06423651 | Recruiting | N/A | Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders | September 1, 2022 | December 31, 2025 |
| NCT04497857 | Recruiting | N/A | Academic-Community EPINET (AC-EPINET) | March 16, 2022 | August 31, 2024 |
| NCT00942981 | Recruiting | Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography | November 13, 2009 | ||
| NCT05890183 | Recruiting | N/A | Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode | May 23, 2023 | May 31, 2028 |
| NCT06005766 | Recruiting | N/A | The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care | September 1, 2023 | December 2026 |
| NCT04144231 | Recruiting | N/A | Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS) | December 19, 2019 | September 6, 2024 |
| NCT06221852 | Recruiting | N/A | Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder | March 12, 2024 | December 30, 2027 |
| NCT04580134 | Recruiting | Phase 4 | CLOZAPINE Response in Biotype-1 | March 1, 2022 | March 31, 2026 |
| NCT06007105 | Recruiting | N/A | SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities | July 18, 2023 | January 31, 2024 |
| NCT05670197 | Recruiting | Service User and Staff Views on Digital Remote Monitoring for Psychosis | November 1, 2022 | December 31, 2023 | |
| NCT06071858 | Recruiting | N/A | Enhanced Coordinated Specialty Care for Early Psychosis | February 1, 2024 | October 2028 |
| NCT04857983 | Recruiting | Phase 2/Phase 3 | Memantine Augmentation of Targeted Cognitive Training in Schizophrenia | July 6, 2021 | December 30, 2024 |
| NCT06159322 | Recruiting | Characterizing Response to Antipsychotics in Schizophrenia | January 1, 2023 | January 30, 2024 | |
| NCT04916626 | Recruiting | N/A | The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis | May 6, 2021 | September 2025 |
| NCT05664594 | Recruiting | N/A | State Representation in Early Psychosis - Project 4 | July 31, 2022 | March 31, 2025 |
| NCT00001486 | Recruiting | Genetic Study of Schizophrenia | July 15, 1995 | ||
| NCT04986072 | Recruiting | Phase 2 | Sodium Nitroprusside in Early Course Schizophrenia | March 14, 2022 | December 22, 2024 |
| NCT03314129 | Recruiting | N/A | Remediation of Visual Perceptual Impairments in People With Schizophrenia | June 1, 2018 | August 31, 2025 |
| NCT05023252 | Recruiting | N/A | Mobile Self-Tracking | October 18, 2021 | September 30, 2024 |
| NCT05030272 | Recruiting | N/A | Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings | September 21, 2021 | April 1, 2025 |
| NCT06182787 | Recruiting | Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient | May 18, 2022 | January 19, 2024 | |
| NCT03708315 | Recruiting | Phase 2 | BXCL501 for Agitation in Schizophrenia | March 9, 2020 | June 2025 |
| NCT06002958 | Recruiting | N/A | Horyzons: Implementation and Integration in Clinical Practice | January 8, 2024 | October 31, 2024 |
| NCT05204407 | Recruiting | N/A | Luteolin for the Treatment of People With Schizophrenia | June 13, 2022 | March 2025 |
| NCT05538832 | Recruiting | Early Phase 1 | Remote State Representation in Early Psychosis | July 27, 2022 | March 31, 2025 |
| NCT05527210 | Recruiting | N/A | Prebiotic Treatment in People With Schizophrenia | January 25, 2023 | January 31, 2026 |
| NCT05208190 | Recruiting | Phase 4 | Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial | March 17, 2022 | February 28, 2027 |
| NCT03495024 | Recruiting | Phase 4 | Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates | January 1, 2019 | June 30, 2020 |
| NCT05273164 | Recruiting | N/A | State Representation in Early Psychosis | December 1, 2021 | March 31, 2025 |
| NCT05464563 | Recruiting | N/A | Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in Schizophrenia | March 22, 2022 | March 2025 |
| NCT01392885 | Recruiting | Brain Health and Exercise in Schizophrenia | July 2011 | December 2026 | |
| NCT05380583 | Recruiting | N/A | Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study | May 19, 2022 | June 30, 2025 |
| NCT04298450 | Recruiting | N/A | ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention | September 21, 2020 | December 2025 |
| NCT00575848 | Terminated | Phase 1 | Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia | December 2007 | October 2008 |
| NCT02796144 | Terminated | Phase 4 | MEtformin and Lorcaserin for WeighT Loss in Schizophrenia | September 2016 | February 14, 2020 |
| NCT01913327 | Terminated | Phase 4 | Antipsychotic Effects on Brain Function in Schizophrenia | April 2013 | January 2017 |
| NCT00857818 | Terminated | Phase 3 | Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome | April 2009 | March 2010 |
| NCT00288353 | Terminated | Phase 3 | Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes | January 2006 | December 2008 |
| NCT01929889 | Terminated | Phase 4 | Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia | April 2012 | October 2014 |
| NCT02949232 | Terminated | Phase 4 | Prednisolone Addition for Patients With Recent-onset Psychotic Disorder | July 2014 | May 2019 |
| NCT00975611 | Terminated | Phase 4 | Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation | October 2009 | January 2012 |
| NCT00314327 | Terminated | Phase 4 | Optimizing Response in Psychosis Study | April 2006 | November 2013 |
| NCT02149823 | Terminated | Phase 1 | Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations | September 2013 | June 14, 2022 |
| NCT02234752 | Terminated | Phase 2 | Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia | September 2014 | July 2016 |
| NCT01368458 | Terminated | N/A | Conversion to Antipsychotic Monotherapy | December 2007 | July 2008 |
| NCT00001198 | Terminated | Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia | March 19, 1984 | October 10, 2017 | |
| NCT01420575 | Terminated | N/A | Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia | October 2010 | August 2012 |
| NCT00511628 | Terminated | Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia | July 2001 | January 2003 | |
| NCT00211302 | Terminated | N/A | Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) | August 2003 | February 2006 |
| NCT00515489 | Terminated | Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients | November 2001 | August 2002 | |
| NCT00517075 | Terminated | Phase 2 | Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) | September 2004 | June 2011 |
| NCT00169026 | Terminated | Phase 4 | Alcoholism and Schizophrenia: Effects of Clozapine | May 1999 | January 2004 |
| NCT00547118 | Terminated | Phase 2 | The Effects of Rimonabant, on Weight and Metabolic Risk Factors | November 2007 | March 2009 |
| NCT00211380 | Terminated | N/A | Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) | August 2003 | February 2006 |
| NCT00591318 | Terminated | Phase 1/Phase 2 | A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis | October 10, 2007 | March 17, 2011 |
| NCT00617214 | Terminated | Schizophrenic Patients Taking Part in Integrated Care Program | January 2008 | December 2008 | |
| NCT02462473 | Terminated | Phase 2 | A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry | May 2015 | January 2016 |
| NCT02476708 | Terminated | N/A | A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia | February 11, 2016 | August 24, 2017 |
| NCT00645229 | Terminated | Phase 3 | A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder | September 2004 | March 2005 |
| NCT01624831 | Terminated | Social Cognition in Longstanding Psychosis | November 2011 | November 2015 | |
| NCT00681629 | Terminated | Phase 4 | Schizophrenic Patients in Integrated Care | July 2008 | November 2008 |
| NCT00701753 | Terminated | A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses | May 2008 | March 2009 | |
| NCT01764568 | Terminated | N/A | Contrasting Group Therapy Methods for Psychosis | January 2013 | June 2022 |
| NCT00715377 | Terminated | N/A | Anticholinergic Burden in Schizophrenia | June 2007 | December 2011 |
| NCT00734435 | Terminated | Phase 2 | Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects | September 2008 | December 2008 |
| NCT02159001 | Unknown status | N/A | Electroconvulsive Therapy in Clozapine-resistant Schizophrenia | June 2014 | June 2018 |
| NCT04093518 | Unknown status | Phase 3 | Estradiol as add-on to Antipsychotics | December 2, 2019 | November 1, 2020 |
| NCT01182012 | Unknown status | Phase 4 | Reduction of Cardiovascular Risk in Severe Mental Illness | August 2010 | December 2012 |
| NCT01729572 | Unknown status | N/A | Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients | January 2014 | August 2015 |
| NCT03576911 | Unknown status | N/A | A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective Disorder | November 2016 | August 2019 |
| NCT00300651 | Unknown status | Phase 3 | Trial of Cognitive Behavioral Therapy for Schizophrenia | March 2006 | August 2009 |
| NCT01398189 | Unknown status | N/A | F-18 Altanserin PET Study of Patients Receiving Clozapine | July 2011 | July 2015 |
| NCT01215383 | Unknown status | The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy | November 2010 | ||
| NCT00192582 | Unknown status | N/A | AIMHI NT Relapse Prevention Trial | July 2005 | August 2007 |
| NCT00885716 | Unknown status | N/A | A Shared Decision Making Training for Inpatients With Schizophrenia | May 2009 | |
| NCT00861003 | Unknown status | An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder | April 2009 | August 2010 | |
| NCT02337439 | Unknown status | N/A | Perceptual Deficits in Schizophrenia | August 2014 | December 2018 |
| NCT00138775 | Unknown status | Phase 2 | Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia | October 2004 | October 2007 |
| NCT01474395 | Unknown status | Phase 2 | N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia | March 2012 | June 2013 |
| NCT03261557 | Unknown status | N/A | Cognitive Behavioral Social Skills Training in Early Onset Psychosis | February 22, 2017 | September 2020 |
| NCT00686400 | Unknown status | A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia | May 2008 | May 2011 | |
| NCT03240380 | Unknown status | N/A | Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. | May 1, 2017 | June 30, 2019 |
| NCT04551027 | Unknown status | N/A | Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness | September 2020 | December 2021 |
| NCT00825045 | Unknown status | N/A | Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia | December 2008 | December 2020 |
| NCT03005574 | Unknown status | N/A | Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program | January 2017 | December 2020 |
| NCT01546467 | Unknown status | N/A | Cognitive Remediation in Early Phase Psychosis | September 2009 | December 2013 |
| NCT04335916 | Unknown status | Survey on Pre-ECT Evaluation and ECT Application | April 1, 2020 | November 1, 2020 | |
| NCT00157313 | Unknown status | N/A | Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis | January 1998 | December 2022 |
| NCT01831986 | Unknown status | N/A | Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders | January 2011 | December 2013 |
| NCT02433717 | Unknown status | Phase 4 | A Pharmacokinetic Study of Paliperidone ER | April 2015 | February 2016 |
| NCT03919760 | Unknown status | Early Psychosis Intervention - Spreading Evidence-based Treatment | January 3, 2020 | May 31, 2024 | |
| NCT04123223 | Unknown status | N/A | Comparing Cognitive Remediation Approaches for Schizophrenia | November 1, 2019 | July 2022 |
| NCT01769014 | Unknown status | Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder | January 2013 | December 2013 | |
| NCT02986490 | Unknown status | N/A | Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs | September 2014 | December 2017 |
| NCT00789022 | Unknown status | Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment | January 2009 | ||
| NCT02529163 | Unknown status | N/A | Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms | August 2015 | July 2019 |
| NCT01320982 | Unknown status | Phase 3 | Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder | March 2011 | July 2012 |
| NCT00435721 | Unknown status | Phase 1 | Families Coping With Mental Illness Program | June 2002 | August 2005 |
| NCT02533232 | Unknown status | Phase 1 | Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia | August 30, 2022 | December 30, 2022 |
| NCT01324167 | Unknown status | Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia | May 2010 | April 2011 | |
| NCT02221635 | Unknown status | Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective | March 2013 | January 2015 | |
| NCT00465283 | Unknown status | Phase 4 | Donepezil Double Blind Trial for ECT Memory Disfunction | May 2007 | January 2010 |
| NCT00465920 | Unknown status | Phase 2 | Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis | May 2007 | April 2010 |
| NCT02665611 | Unknown status | N/A | Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence | February 2016 | January 2018 |
| NCT00469664 | Unknown status | Phase 4 | Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia | February 2000 | December 2008 |
| NCT01280305 | Unknown status | Phase 3 | Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder | March 2011 | March 2013 |
| NCT05140135 | Withdrawn | N/A | Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy | January 11, 2021 | December 31, 2025 |
| NCT02661347 | Withdrawn | N/A | Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia | February 2016 | December 1, 2016 |
| NCT00672464 | Withdrawn | Phase 4 | Cardio Risk of Acute Schizophrenia Olanzapine Duke | April 2008 | February 2010 |
| NCT00534898 | Withdrawn | Phase 3 | Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients | ||
| NCT02197286 | Withdrawn | Phase 2 | Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia | February 2015 | |
| NCT00440843 | Withdrawn | Phase 3 | Zyprexa and Task Engagement in Schizophrenia | February 2007 | June 2012 |
| NCT05338424 | Withdrawn | Exercise Target Brain Oscillations in Psychosis | July 1, 2022 | September 30, 2022 | |
| NCT03061136 | Withdrawn | Phase 4 | Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia | October 2016 | October 2017 |
- Disase is a (Disease Ontology)
- DOID:2468
- Cross Reference ID (Disease Ontology)
- ICD10CM:F25
- Cross Reference ID (Disease Ontology)
- ICD9CM:295.7
- Cross Reference ID (Disease Ontology)
- MESH:D011618
- Cross Reference ID (Disease Ontology)
- NCI:C94378
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:231490005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0036337